Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Irene Canales Ruiz"'
Autor:
Irene Canales Ruiz, Maurizio Martelli, Laurie H. Sehn, Umberto Vitolo, Tina G. Nielsen, Gila Sellam, Alessia Bottos, Dirk Klingbiel, Lale Kostakoglu
Publikováno v:
Clinical lymphoma, myelomaleukemia. 22(8)
Introduction A good response to initial therapy is key to maximizing survival in patients with diffuse large B-cell lymphoma (DLBCL), but patients with chemorefractory disease and early progression have poor outcomes. Patients and Methods Data from t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2c388cf70bd751d84062474e9fce17c
https://pubmed.ncbi.nlm.nih.gov/35595618
https://pubmed.ncbi.nlm.nih.gov/35595618
Autor:
R. Ho, Andrea Knapp, Per-Olof Thuresson, Irene Canales Ruiz, Leonardo Simonella, Aino Launonen
Publikováno v:
Blood. 138:3577-3577
Background: Most patients (pts) with diffuse large B-cell lymphoma (DLBCL) receiving first-line (1L) rituximab plus CHOP (R-CHOP) have similar mortality to the general population (gen popn) if they are progression-free at 24 months (PFS24; Maurer et
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bf181e90dd44995056a6038e79617396
https://doi.org/10.1182/blood-2021-146822
https://doi.org/10.1182/blood-2021-146822